Heart Risks Associated With Bextra. Kaiser Permanente, the nation’s largest not-for-profit managed-care provider, has stopped prescribing Bextra until tests show whether the painkiller is safe.
The decision came amid “compelling” evidence of heightened heart risks associated with Bextra and a similar drug called Vioxx that manufacturer Merck & Co. pulled from the market in September, according to a company memo Kaiser issued late Friday.
Kaiser spokeswoman Beverly Hayon said the policy, which Kaiser is calling a moratorium, represents the first time the health system’s doctors had decided to stop dispensing a drug that was approved by the Food and Drug Administration.
The Oakland-based HMO, hospital and clinic network, which serves 8.5 million patients
The Oakland-based HMO, hospital and clinic network, which serves 8.5 million patients in nine states and the District of Columbia, plans to stop filling new prescriptions for Bextra on Feb. 1 and on March 1 for refills.
Physicians will be notified with suggestions for alternative medicines they can prescribe. Bextra, made by Pfizer Inc., is most often recommended for arthritis patients.
“This is not a drug that saves lives,” said Dr. Sharon Levine, who oversees medication usage for Kaiser Permanente’s Northern California division. “It’s a drug that provides a modest degree of pain relief no better than Motrin and the size of the risk, given the benefit provided, did not seem warranted.”
Need Legal Help Regarding Bextra?
The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529.
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Call us at: 1-800-YOURLAWYER (800-968-7529) | Schedule your free consultation
Our Bextra lawsuit lawyers are here to help you when you need it the most.
